J Cami

Summary

Affiliation: Hospital del Mar
Country: Spain

Publications

  1. ncbi request reprint [Bibliometric map of Spain 1994-2002: biomedicine and health sciences]
    Jordi Camí
    Institut Municipal d Investigacio Medica IMIM, Barcelona, Spain
    Med Clin (Barc) 124:93-101. 2005
  2. ncbi request reprint [Spanish scientific production in biomedicine and health sciences during the period 1990-1993 (Science Citation Index and Social Science Citation Index) and comparison to period 1986-1989]
    J Cami
    Institut Municipal d Investigacio Medica IMIM, Barcelona
    Med Clin (Barc) 109:481-96. 1997
  3. ncbi request reprint Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects
    J Cami
    Pharmacology Unit, Institut Muncipal d Investigació Mèdica, Barcelona, Spain
    J Clin Psychopharmacol 20:455-66. 2000
  4. ncbi request reprint Drug addiction
    Jordi Camí
    Institut Municipal d Investigacio Medica, Universitat Pompeu Fabra, Barcelona, Spain
    N Engl J Med 349:975-86. 2003
  5. pmc Non-linear pharmacokinetics of MDMA ('ecstasy') in humans
    R de la Torre
    Pharmacology Research Unit, Institut Municipal d Investigacio Medica IMIM, Universitat Pompeu Fabra and Universitat Autònoma de Barcelona, Spain
    Br J Clin Pharmacol 49:104-9. 2000
  6. doi request reprint Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart
    A M Peiró
    Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Programme, IMIM Hospital del Mar Medical Research Institute, Doctor Aiguader 88, 08003 Barcelona, Spain
    Psychopharmacology (Berl) 225:883-93. 2013
  7. ncbi request reprint Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics
    M Farre
    Pharmacology Unit, Institut Municipal d Investigacio Medica, Doctor Aiguader 80, 08003 Barcelona, Spain
    Psychopharmacology (Berl) 173:364-75. 2004
  8. ncbi request reprint Pharmacology of MDMA in humans
    - de la Torre R
    Pharmacology Unit, Institut Municipal d Investigacio Medica, Universitat Autonoma de Barcelona, Spain
    Ann N Y Acad Sci 914:225-37. 2000
  9. ncbi request reprint MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers
    Rafael de la Torre
    Pharmacology Unit, Institut Municipal d Investigacio Medica IMIM, Doctor Aiguader 80, 08003 Barcelona, Spain
    Eur J Clin Pharmacol 61:551-4. 2005
  10. ncbi request reprint Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition
    Rafael de la Torre
    Unitat de Recerca en Farmacologia, Institut Municipal d Investigacio Medica, Barcelona, Spain
    Ther Drug Monit 26:137-44. 2004

Collaborators

Detail Information

Publications15

  1. ncbi request reprint [Bibliometric map of Spain 1994-2002: biomedicine and health sciences]
    Jordi Camí
    Institut Municipal d Investigacio Medica IMIM, Barcelona, Spain
    Med Clin (Barc) 124:93-101. 2005
    ..The present study is a 1994-2002 update of the Spanish biomedical bibliometric map that follows other reports already published in Medicina Clinica concerning the previous periods 1986-1989 and 1990-1993...
  2. ncbi request reprint [Spanish scientific production in biomedicine and health sciences during the period 1990-1993 (Science Citation Index and Social Science Citation Index) and comparison to period 1986-1989]
    J Cami
    Institut Municipal d Investigacio Medica IMIM, Barcelona
    Med Clin (Barc) 109:481-96. 1997
    ..This paper analyses the period 1990-1993, offers a wider coverage including the Social Science Citation Index (SSCI) database, and compares both time periods...
  3. ncbi request reprint Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects
    J Cami
    Pharmacology Unit, Institut Muncipal d Investigació Mèdica, Barcelona, Spain
    J Clin Psychopharmacol 20:455-66. 2000
    ..These data support the abuse liability of MDMA...
  4. ncbi request reprint Drug addiction
    Jordi Camí
    Institut Municipal d Investigacio Medica, Universitat Pompeu Fabra, Barcelona, Spain
    N Engl J Med 349:975-86. 2003
  5. pmc Non-linear pharmacokinetics of MDMA ('ecstasy') in humans
    R de la Torre
    Pharmacology Research Unit, Institut Municipal d Investigacio Medica IMIM, Universitat Pompeu Fabra and Universitat Autònoma de Barcelona, Spain
    Br J Clin Pharmacol 49:104-9. 2000
    ..A clinical trial was designed for the evaluation of MDMA pharmacological effects and pharmacokinetics in healthy volunteers...
  6. doi request reprint Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart
    A M Peiró
    Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Programme, IMIM Hospital del Mar Medical Research Institute, Doctor Aiguader 88, 08003 Barcelona, Spain
    Psychopharmacology (Berl) 225:883-93. 2013
    ..3,4-methylenedioxymethamphetamine (MDMA, ecstasy) is one of the most abused recreational drugs. Its usual pattern of misuse includes repeated doses taken over a short time period that could influence MDMA pharmacology and toxicity...
  7. ncbi request reprint Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics
    M Farre
    Pharmacology Unit, Institut Municipal d Investigacio Medica, Doctor Aiguader 80, 08003 Barcelona, Spain
    Psychopharmacology (Berl) 173:364-75. 2004
    ..MDMA presents non-linear pharmacokinetics, probably by inhibition of cytochrome P450 isoform 2D6. Users are known to often take more than one dose per session. This practice could have serious implications for the toxicity of MDMA...
  8. ncbi request reprint Pharmacology of MDMA in humans
    - de la Torre R
    Pharmacology Unit, Institut Municipal d Investigacio Medica, Universitat Autonoma de Barcelona, Spain
    Ann N Y Acad Sci 914:225-37. 2000
    ..Both peak concentrations and peak effects were obtained between 1 and 2 h and decreased to baseline values 4-6 h after drug administration...
  9. ncbi request reprint MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers
    Rafael de la Torre
    Pharmacology Unit, Institut Municipal d Investigacio Medica IMIM, Doctor Aiguader 80, 08003 Barcelona, Spain
    Eur J Clin Pharmacol 61:551-4. 2005
  10. ncbi request reprint Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition
    Rafael de la Torre
    Unitat de Recerca en Farmacologia, Institut Municipal d Investigacio Medica, Barcelona, Spain
    Ther Drug Monit 26:137-44. 2004
    ..One of the interesting features of MDMA metabolism is its potential involvement in the development of mid- to long-term neurotoxic effects as a result of progressive neurodegeneration of the serotonergic neurotransmission system...
  11. ncbi request reprint Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis
    Magi Farre
    Pharmacology Unit Institut Municipal d Investigacio Mèdica IMIM, Carrer Doctor Aiguador 80, E 08003, Barcelona, Spain
    Drug Alcohol Depend 65:283-90. 2002
    ..92, 95% CI 1.32--2.78). It is proposed that in agonist-maintenance programmes, oral methadone at doses of 50 mg/day or higher is the drug of choice for opioid dependence...
  12. ncbi request reprint 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics
    Cándido Hernández-López
    Unit of Pharmacology, Institut Municipal d Investigacio Medica, Hospital del Mar, Barcelona, Spain
    J Pharmacol Exp Ther 300:236-44. 2002
    ..Confirmation of these findings in further studies will be highly relevant in terms of road safety...
  13. ncbi request reprint Effect of quinolones on caffeine disposition
    M Carbo
    Department of Pharmacology and Toxicology, Institut Municipal d Investigacio Medica, Barcelona, Spain
    Clin Pharmacol Ther 45:234-40. 1989
    ..In two additional healthy volunteers under a controlled multiple-dose regimen of caffeine ingestion, administration of pipemidic acid for 2 days caused a fourfold increase in the plasma concentrations of caffeine...
  14. doi request reprint Is there an association between the quality of hospitals' research and their quality of care?
    Joan Pons
    Catalan Agency for Health Technology Assessment and Research, Department of Health, Barcelona, Spain
    J Health Serv Res Policy 15:204-9. 2010
    ..Our aim was to determine whether there is a relationship between bibliometric measures of research output in acute hospitals and hospital mortality for two common cardiac conditions...
  15. ncbi request reprint Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis
    Nieves Pizarro
    Pharmacology Research Unit, Institut Municipal d Investigacio Medica IMIM, Barcelona, Spain
    J Anal Toxicol 26:157-65. 2002
    ..Stereoselective disposition of MDMA and MDA was confirmed. HMMA disposition seems to be in apparent contradiction with MDMA findings as the enantiomer ratio is close to 1 and constant over the time...